Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2023 Filed Mar 27, 2023 20:43 UTC |
Bassler Bonnie LDirector
|
Exercise / conversionCommon Stock | 1,240 | $380.95 | $472,378.00 |
DisclosureSEC source: 0001883850-23-000064 · edgardoc.xml · nonDerivative · entry 1 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 4, 2022. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:42 UTC |
VAGELOS P ROYDirector
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001883850-23-000063 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,578 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 21, 2022. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 400 | $810.30 | $324,120.00 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 8 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 196,848 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 700 | $806.47 | $564,529.00 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 7 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 197,248 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 47 | $805.55 | $37,860.85 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 6 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 197,948 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 254 | $804.38 | $204,312.52 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 5 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 197,995 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F7 · price: Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $804.00 to $804.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 642 | $803.30 | $515,718.60 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 4 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 198,249 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F6 · price: Represents volume-weighted average price of sales of 642 shares of Company stock on March 23, 2023 at prices ranging from $803.01 to $803.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 1,237 | $802.54 | $992,741.98 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 3 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 198,891 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F5 · price: Represents volume-weighted average price of sales of 1,237 shares of Company stock on March 23, 2023 at prices ranging from $802.00 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 122 | $801.16 | $97,741.52 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 2 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 200,128 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F4 · price: Represents volume-weighted average price of sales of 122 shares of Company stock on March 23, 2023 at prices ranging from $801.00 to $801.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:41 UTC |
YANCOPOULOS GEORGEDirector · President and Chief Scientific
|
SaleCommon Stock | 254 | $800.59 | $203,349.86 |
DisclosureSEC source: 0001883850-23-000062 · edgardoc.xml · nonDerivative · entry 1 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and Chief Scientific 10b5-1 filing: Plan reported Ownership: Indirect · By Trust for Chldn. Disclosed balance after: 200,250 F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022. F2 · price: Represents volume-weighted average price of sales of 254 shares of Company stock on March 23, 2023 at prices ranging from $800.52 to $800.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 23, 2023 at each separate price. F3 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:39 UTC |
LAROSA JOSEPH JEVP General Counsel and Secret
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $270.43 | $0.00 |
DisclosureSEC source: 0001883850-23-000061 · edgardoc.xml · derivative · entry 5 LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:39 UTC |
LAROSA JOSEPH JEVP General Counsel and Secret
|
Tax withholdingCommon Stock | 6,742 | $801.59 | $5,404,319.78 |
DisclosureSEC source: 0001883850-23-000061 · edgardoc.xml · nonDerivative · entry 2 LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,471 Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:39 UTC |
LAROSA JOSEPH JEVP General Counsel and Secret
|
Exercise / conversionCommon Stock | 10,000 | $270.43 | $2,704,300.00 |
DisclosureSEC source: 0001883850-23-000061 · edgardoc.xml · nonDerivative · entry 1 LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:37 UTC |
Fenimore Christopher R.SVP Controller
|
SaleCommon Stock | 2,192 | $806.47 | $1,767,782.24 |
DisclosureSEC source: 0001883850-23-000060 · edgardoc.xml · nonDerivative · entry 1 Fenimore Christopher R. · CIK 0001697422 · SVP Controller 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,409 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 9, 2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:08 UTC |
LAROSA JOSEPH JEVP General Counsel and Secret
|
GiftCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001968202-23-000002 · edgardoc.xml · nonDerivative · entry 1 LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 GRAT Disclosed balance after: 0 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 7 | $766.32 | $5,364.24 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 9 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,147 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F10 · price: Represents volume-weighted average price of sales of 7 shares of Company stock on March 1, 2023 at prices ranging from $766.02 to $766.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 10 | $765.55 | $7,655.50 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 8 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,154 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2023 at prices ranging from $765.10 to $765.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 17 | $764.49 | $12,996.33 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 7 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,164 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 17 shares of Company stock on March 1, 2023 at prices ranging from $764.20 to $764.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 11 | $763.51 | $8,398.61 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 6 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,181 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 11 shares of Company stock on March 1, 2023 at prices ranging from $763.18 to $763.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 9 | $762.28 | $6,860.52 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 5 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,192 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on March 1, 2023 at prices ranging from $762.11 to $762.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 16 | $761.62 | $12,185.92 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 4 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,201 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 16 shares of Company stock on March 1, 2023 at prices ranging from $761.11 to $761.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 10 | $760.54 | $7,605.40 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 3 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,217 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2023 at prices ranging from $760.00 to $760.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 15 | $759.48 | $11,392.20 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,227 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 15 shares of Company stock on March 1, 2023 at prices ranging from $759.02 to $759.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 5 | $758.20 | $3,791.00 |
DisclosureSEC source: 0001883850-23-000054 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,242 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 5 shares of Company stock on March 1, 2023 at prices ranging from $758.16 to $758.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2023 at each separate price. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,100 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001883850-23-000053 · edgardoc.xml · derivative · entry 4 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,550 Underlying: Common Stock · 1,100 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
McCourt MarionEVP Commercial
|
SaleCommon Stock | 1,100 | $759.89 | $835,879.00 |
DisclosureSEC source: 0001883850-23-000053 · edgardoc.xml · nonDerivative · entry 2 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,803 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:03 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionCommon Stock | 1,100 | $372.46 | $409,706.00 |
DisclosureSEC source: 0001883850-23-000053 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:07 UTC |
VAGELOS P ROYDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 42,500 | $0.00 Strike: $270.43 | $0.00 |
DisclosureSEC source: 0001883850-23-000050 · edgardoc.xml · derivative · entry 7 VAGELOS P ROY · CIK 0001013064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 42,500 shares Expires 2023-12-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:07 UTC |
VAGELOS P ROYDirector
|
Tax withholdingCommon Stock | 29,005 | $750.16 | $21,758,390.80 |
DisclosureSEC source: 0001883850-23-000050 · edgardoc.xml · nonDerivative · entry 2 VAGELOS P ROY · CIK 0001013064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,578 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:07 UTC |
VAGELOS P ROYDirector
|
Exercise / conversionCommon Stock | 42,500 | $270.43 | $11,493,275.00 |
DisclosureSEC source: 0001883850-23-000050 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2023 Filed Feb 14, 2023 21:24 UTC |
McCourt MarionEVP Commercial
|
Tax withholdingCommon Stock | 1,276 | $751.78 | $959,271.28 |
DisclosureSEC source: 0001883850-23-000048 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,803 Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 21:14 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001883850-23-000043 · edgardoc.xml · derivative · entry 4 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 Underlying: Common Stock · 1,000 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 21:14 UTC |
McCourt MarionEVP Commercial
|
SaleCommon Stock | 1,000 | $769.04 | $769,040.00 |
DisclosureSEC source: 0001883850-23-000043 · edgardoc.xml · nonDerivative · entry 2 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,079 Read SEC document |
| February 07, 2023 Filed Feb 8, 2023 21:14 UTC |
McCourt MarionEVP Commercial
|
Exercise / conversionCommon Stock | 1,000 | $372.46 | $372,460.00 |
DisclosureSEC source: 0001883850-23-000043 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · EVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 28 | $797.43 | $22,328.04 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 17 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,105 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 18 | $796.43 | $14,335.74 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 16 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,133 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 18 shares of Company stock on February 6, 2023 at prices ranging from $796.35 to $796.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 59 | $795.41 | $46,929.19 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 15 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,151 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 59 shares of Company stock on February 6, 2023 at prices ranging from $795.26 to $795.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 99 | $794.61 | $78,666.39 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 14 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,210 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $794.28 to $794.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 2 | $793.33 | $1,586.66 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 13 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,309 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 3 | $791.00 | $2,373.00 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 12 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,311 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 10 | $790.41 | $7,904.10 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 11 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,314 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 49 | $789.05 | $38,663.45 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 10 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,324 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 99 | $788.62 | $78,073.38 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 9 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,373 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 99 shares of Company stock on February 6, 2023 at prices ranging from $788.48 to $788.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 58 | $787.47 | $45,673.26 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 8 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,472 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 85 | $786.45 | $66,848.25 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 7 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,530 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 85 shares of Company stock on February 6, 2023 at prices ranging from $786.03 to $786.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 78 | $785.88 | $61,298.64 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 6 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,615 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 78 shares of Company stock on February 6, 2023 at prices ranging from $785.85 to $785.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 113 | $784.27 | $88,622.51 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 5 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,693 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 113 shares of Company stock on February 6, 2023 at prices ranging from $784.02 to $784.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 6, 2023 at each separate price. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:09 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 51 | $783.05 | $39,935.55 |
DisclosureSEC source: 0001883850-23-000035 · edgardoc.xml · nonDerivative · entry 4 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,806 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:16 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,613 | $0.00 Strike: $482.68 | $0.00 |
DisclosureSEC source: 0001883850-23-000046 · edgardoc.xml · derivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,613 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:16 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 3,613 | $800.00 | $2,890,400.00 |
DisclosureSEC source: 0001883850-23-000046 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.